Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan
- Status
- COMPLETED
- Phase
- PHASE3
PK of Serelaxin in Severe Renal Impairment and ESRD
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE2
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Muscle Effects of BYM338 in Mechanically Ventilated Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension
- Status
- WITHDRAWN
- Phase
- PHASE3
Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease
- Status
- WITHDRAWN
- Phase
- PHASE1
Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Extension in AS: Sustainability of Benefits, Safety and Tolerability
- Status
- COMPLETED
- Phase
- PHASE3
Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type II Diabetes
- Status
- TERMINATED
- Phase
- PHASE4
A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection
- Status
- COMPLETED
- Phase
- PHASE2
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
- Status
- WITHDRAWN
- Phase
- PHASE3
Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins
- Status
- COMPLETED
- Phase
- PHASE1